Cargando…
Can Serum Cystatin C predict long-term survival in cardiac surgery patients?
Renal dysfunction is a risk factor for morbidity and mortality in cardiac surgery patients. Serum Cystatin C (sCysC) is a well-recognized marker of early renal dysfunction but few reports evaluate its prognostic cardio-vascular role. The aim of the study is to consider the prognostic value of sCysC...
Autores principales: | Rovella, Valentina, Marrone, Giulia, Dessì, Mariarita, Ferrannini, Michele, Toschi, Nicola, Pellegrino, Antonio, Casasco, Maurizio, Di Daniele, Nicola, Noce, Annalisa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5892696/ https://www.ncbi.nlm.nih.gov/pubmed/29615540 http://dx.doi.org/10.18632/aging.101403 |
Ejemplares similares
-
Fenoldopam Mesylate: A Narrative Review of Its Use in Acute Kidney Injury
por: Noce, Annalisa, et al.
Publicado: (2019) -
MOSH Syndrome (Male Obesity Secondary Hypogonadism): Clinical Assessment and Possible Therapeutic Approaches
por: De Lorenzo, Antonino, et al.
Publicado: (2018) -
Biomarkers of Glyco-Metabolic Control in Hemodialysis Patients: Glycated Hemoglobin vs. Glycated Albumin
por: Martino, Francesca Gabriela, et al.
Publicado: (2021) -
Impact of Gut Microbiota Composition on Onset and Progression of Chronic Non-Communicable Diseases
por: Noce, Annalisa, et al.
Publicado: (2019) -
Impact of Mediterranean diet on metabolic syndrome, cancer and longevity
por: Di Daniele, Nicola, et al.
Publicado: (2016)